These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18925509)

  • 1. Lysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.
    Khandoga AL; Fujiwara Y; Goyal P; Pandey D; Tsukahara R; Bolen A; Guo H; Wilke N; Liu J; Valentine WJ; Durgam GG; Miller DD; Jiang G; Prestwich GD; Tigyi G; Siess W
    Platelets; 2008 Sep; 19(6):415-27. PubMed ID: 18925509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
    Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
    Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombogenic and atherogenic activities of lysophosphatidic acid.
    Siess W; Tigyi G
    J Cell Biochem; 2004 Aug; 92(6):1086-94. PubMed ID: 15258894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet-monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors.
    Haserück N; Erl W; Pandey D; Tigyi G; Ohlmann P; Ravanat C; Gachet C; Siess W
    Blood; 2004 Apr; 103(7):2585-92. PubMed ID: 14645014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
    Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
    Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysophosphatidic acid is the unique platelet-activating substance in human malignant ascites.
    Sandmann G; Siess W; Essler M
    Eur J Med Res; 2003 Sep; 8(9):397-404. PubMed ID: 14555295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique ligand selectivity of the GPR92/LPA5 lysophosphatidate receptor indicates role in human platelet activation.
    Williams JR; Khandoga AL; Goyal P; Fells JI; Perygin DH; Siess W; Parrill AL; Tigyi G; Fujiwara Y
    J Biol Chem; 2009 Jun; 284(25):17304-17319. PubMed ID: 19366702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure-activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARgamma, and inhibitors of autotaxin.
    Durgam GG; Virag T; Walker MD; Tsukahara R; Yasuda S; Liliom K; van Meeteren LA; Moolenaar WH; Wilke N; Siess W; Tigyi G; Miller DD
    J Med Chem; 2005 Jul; 48(15):4919-30. PubMed ID: 16033271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
    Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
    ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual heterogeneity in platelet response to lysophosphatidic acid: evidence for a novel inhibitory pathway.
    Pamuklar Z; Lee JS; Cheng HY; Panchatcharam M; Steinhubl S; Morris AJ; Charnigo R; Smyth SS
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):555-61. PubMed ID: 18202325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.
    Durgam GG; Tsukahara R; Makarova N; Walker MD; Fujiwara Y; Pigg KR; Baker DL; Sardar VM; Parrill AL; Tigyi G; Miller DD
    Bioorg Med Chem Lett; 2006 Feb; 16(3):633-40. PubMed ID: 16263282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR92/LPA₅ lysophosphatidate receptor mediates megakaryocytic cell shape change induced by human atherosclerotic plaques.
    Khandoga AL; Pandey D; Welsch U; Brandl R; Siess W
    Cardiovasc Res; 2011 Apr; 90(1):157-64. PubMed ID: 21106562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.
    Fischer DJ; Liliom K; Guo Z; Nusser N; Virág T; Murakami-Murofushi K; Kobayashi S; Erickson JR; Sun G; Miller DD; Tigyi G
    Mol Pharmacol; 1998 Dec; 54(6):979-88. PubMed ID: 9855625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective non-lipid modulator of LPA5 activity in human platelets.
    Kozian DH; Evers A; Florian P; Wonerow P; Joho S; Nazare M
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5239-43. PubMed ID: 22801643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphonothioate and fluoromethylene phosphonate analogues of cyclic phosphatidic acid: Novel antagonists of lysophosphatidic acid receptors.
    Xu Y; Jiang G; Tsukahara R; Fujiwara Y; Tigyi G; Prestwich GD
    J Med Chem; 2006 Aug; 49(17):5309-15. PubMed ID: 16913720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.
    Gerrard JM; Kindom SE; Peterson DA; Peller J; Krantz KE; White JG
    Am J Pathol; 1979 Aug; 96(2):423-38. PubMed ID: 112871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic activation of human platelets by lysophosphatidic acid and adrenaline.
    Nilsson U; Svensson SP; Grenegård M
    Haematologica; 2002 Jul; 87(7):730-9; discussion 739. PubMed ID: 12091124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Darmstoff analogs as selective agonists and antagonists of lysophosphatidic acid receptors.
    Gududuru V; Zeng K; Tsukahara R; Makarova N; Fujiwara Y; Pigg KR; Baker DL; Tigyi G; Miller DD
    Bioorg Med Chem Lett; 2006 Jan; 16(2):451-6. PubMed ID: 16290140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts.
    Maeda-Sano K; Gotoh M; Morohoshi T; Someya T; Murofushi H; Murakami-Murofushi K
    Biochim Biophys Acta; 2014 Sep; 1841(9):1256-63. PubMed ID: 24845645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.